Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering CorpfiledCriticalSchering Corp
Priority to MX9603834ApriorityCriticalpatent/MX9603834A/es
Publication of MXPA96003834ApublicationCriticalpatent/MXPA96003834A/es
Publication of MX9603834ApublicationCriticalpatent/MX9603834A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se presenta un método para el tratamiento de astrocitoma de alto grado, especialmente glioma de tronco cerebral, en un niño mediante la administracion a un niño que requiere de tal tratamiento de una cantidad de temozolomida suficiente para lograr una respuesta clinica. Se proporcionan esquemas preferidos de dosificacion.
MX9603834A1996-09-031996-09-03Metodo para crear astrocitoma pediatrico de alto grado que incluye glioma de tronco cerebral.
MX9603834A
(es)
Use of 9-deoxy-2',9-methano-3-oxa-4,5,6-trinor-3,7-(1',3'interphenylene)-13,14-dihydroprostaglandin F1 to treat peripheral vascular disease
Sulphonamidic compounds as therapeutic agents for treatment of central nervous system, method of obtaining novel sulphonamidic compounds and drugs containing such compounds
1,4-benzodiazepines condesed with 5- and 6-membered heterocyclic rings to treat anxiety, pain, pupil constriction, withdrawal-syndrome or oncologic disorders